Axogen Inc vs Vanguard Growth Index Fund ETF — how do they compare? Axogen Inc trades at $38.87 (market cap $2.06B), while Vanguard Growth Index Fund ETF trades at $87.69. Which is the better fit depends on your goals.
| AXGN | VUG | |
|---|---|---|
Market Cap | $2.06B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $46.19 | $90.29 |
52-Week Low | $11.28 | $70.00 |
Enterprise Value | $1.98B | — |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
VUG trades at $86.15, down 1.43% on the day, with a neutral technical signal and bullish moving averages. Recent news highlights its low 0.03% expense ratio and 411% total return over the past decade. The ETF is heavily concentrated in technology stocks (70% of assets) and executed a 1:6 stock split in April 2026.
Outlook remains positive for long-term growth investors given strong historical performance and cost efficiency, though high tech exposure and market volatility present risks. The fund's ability to adapt to economic growth trends supports its appeal, but investors should weigh concentration risk against diversification benefits.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.
Read more on VUG →